Supplementary Figure 2: Stability of prefusion RSV F glycoprotein immunogens.
From: Iterative structure-based improvement of a fusion-glycoprotein vaccine against RSV
Decay curves at 60oC for RSV F glycoprotein immunogens of (a) design cycle 3 and (b) design cycle 4 were assessed by Octet BLI using prefusion-specific antibodies AM14, D25 and MPE8.
